News
LUMIER PHARM LLC successfully supplied the medicinal product RITUXIM, concentrate for solution for infusions of 100 mg / 10 ml in vials # 2; 500 mg / 50 ml vial # 1 by UNDP
According to the Resolution of the Cabinet of Ministers of Ukraine of March 28, 2018 No. 278 “On approval of the list of medicines and medical devices purchased on the basis of procurement agreements with specialized organizations that procure by directions of use of budget funds in 2018 under the program“ Provision medical measures of individual state programs and complex measures of a programmatic character ”», namely by programs:
- Chemotherapeutic drugs, radiopharmaceuticals and accompanying preparations for the treatment of cancer patients: Medications for patients suffering from cancer-hematological diseases;
- Medicines and medical products for the treatment of children suffering from cancer and onco-hematological diseases
LUMIER PHARM LLC successfully supplied the medicinal product RITUXIM, concentrate for solution for infusions of 100 mg / 10 ml in vials # 2; 500 mg / 50 ml per bottle # 1 »by UNDP within the framework of the tenders conducted by the Ministry of Health.
2 July 2018
© 2008 - 2012 Lumier Pharma. All rights reserved.
© 2012 made by mc design
mc design - Creative Design Lab
© 2012 made by mc design